Why psychedelics may get FDA approval this summer (TED Radio Hour+) TED Radio Hour
-
- Technology
Next month, the FDA is set to decide whether MDMA-assisted therapy will become a legal and accessible treatment for PTSD. In this bonus episode, host Manoush Zomorodi talks with Rick Doblin, a pioneer in psychedelics research. Rick was featured in the episode "Through The Looking Glass" (https://n.pr/3WEJGIY). They talk about his group's work and the potential FDA approval.
Since Manoush spoke to Rick, there have been questions raised about the clinical trial process. Learn more on NPR at https://www.npr.org/sections/health-shots/2024/05/13/1250580932/ecstasy-mdma-ptsd-fda-approval.
To get access to this and other bonus episodes, sign up for TED Radio Hour+. When you do, all your episodes also become sponsor-free. That's because you are directly supporting our work at NPR. Learn more at plus.npr.org/ted
Next month, the FDA is set to decide whether MDMA-assisted therapy will become a legal and accessible treatment for PTSD. In this bonus episode, host Manoush Zomorodi talks with Rick Doblin, a pioneer in psychedelics research. Rick was featured in the episode "Through The Looking Glass" (https://n.pr/3WEJGIY). They talk about his group's work and the potential FDA approval.
Since Manoush spoke to Rick, there have been questions raised about the clinical trial process. Learn more on NPR at https://www.npr.org/sections/health-shots/2024/05/13/1250580932/ecstasy-mdma-ptsd-fda-approval.
To get access to this and other bonus episodes, sign up for TED Radio Hour+. When you do, all your episodes also become sponsor-free. That's because you are directly supporting our work at NPR. Learn more at plus.npr.org/ted